Try our Advanced Search for more refined results
Competition
-
February 02, 2026
DOJ Opposes Google's Bid For Partial Search Remedy Pause
The U.S. Department of Justice and state enforcers are opposing Google's bid to pause parts of the remedies imposed after a D.C. federal court found it monopolized the search market, while the tech giant appeals the ruling to the D.C. Circuit.
-
February 02, 2026
Judge Skeptical Of XAI's Claims In OpenAI Trade Secrets Suit
A California federal judge has said she's inclined to grant OpenAI's motion to dismiss a trade secrets complaint from Elon Musk's xAI "in full," saying the plaintiffs have not provided enough facts to support claims that OpenAI poached employees and stole source code.
-
February 02, 2026
House Lawmakers Set To Weigh FirstNet Renewal Bill
U.S. House members Wednesday will consider legislative plans to renew the First Responder Network Authority for just over a decade beyond its scheduled sunset next year and also will examine whether to impose more federal oversight on the network.
-
February 02, 2026
NFL, Fanatics Bolster Attempt To Toss Fans' Monopoly Suit
The NFL and Fanatics pushed a New York federal court to toss a fan lawsuit that accused the pair of monopolizing the online retail market for league merchandise, arguing a previously dismissed lawsuit already found the plaintiffs' arguments defective.
-
February 02, 2026
Paul Weiss Expands DC Antitrust Team With Davis Polk Atty
An attorney specializing in advising clients on high-profile mergers and acquisitions has moved his practice to Paul Weiss Rifkind Wharton & Garrison LLP's Washington, D.C., office after nearly 20 years with Davis Polk & Wardwell LLP.
-
February 02, 2026
Bausch, Lannett To Pay $17.9M In Drug Price-Fixing Deal
Lannett Company Inc., Bausch Health US LLC and Bausch Health America Inc. will pay $17.85 million to settle allegations by 48 states and territories that they conspired to fix prices for generic drugs, according to a motion filed Monday seeking preliminary approval of the deal.
-
February 02, 2026
Akin Gov't Investigation Pros Move To Simpson Thacher In DC
Three former leaders of Akin Gump Strauss Hauer & Feld LLP's congressional investigations and state attorneys general practices have jumped to Simpson Thacher & Bartlett LLP in Washington, D.C.
-
January 30, 2026
Kroger, Albertsons Look To Block FTC Testimony Handover
Grocery giants Albertsons and Kroger asked a California federal judge to protect sensitive expert testimony that helped the Federal Trade Commission torpedo their planned merger in 2024, which a new FTC target said is urgently needed to show that the regulator is creating contradictory market analyses.
-
January 30, 2026
FTC Taps Goodwin Atty For Consumer Protection Deputy Role
A veteran of Goodwin Procter LLP has been tapped to serve as deputy director of the Federal Trade Commission's Bureau of Consumer Protection, the regulator announced.
-
January 30, 2026
OpenAI Challenges X's Deposition Bid In Antitrust Case
OpenAI said one of its former executives shouldn't be deposed in an antitrust case brought by X Corp. regarding ChatGPT integration on Apple devices, saying he had nothing to do with the deal.
-
January 30, 2026
Live Nation Plaintiff States Fight Plan To Stay Antitrust Claims
Nearly three dozen states accusing Live Nation of stifling competition in the live entertainment industry urged a New York federal judge not to pause their state-law claims in order to focus on federal law, arguing that handling all claims at once "will be the most efficient approach."
-
January 30, 2026
'Inferential Leap' Kills Academic Researchers' Conspiracy Suit
A New York federal judge took a proposed class of academic researchers to task Friday, permanently dismissing their lawsuit accusing six of academia's largest journal publishers of colluding to stifle their leverage and eliminate pay for peer review work, finding that the publishers' rules being contested do nothing of the sort.
-
January 30, 2026
UP, Norfolk Southern Rip Rival BNSF's Merger Docs Demands
Union Pacific and Norfolk Southern have accused rival railroad BNSF Railway of trying to delay the regulatory review for their proposed $85 billion mega-merger by demanding that they share thousands more documents, emails and other operational details in what they called a "fishing expedition."
-
January 30, 2026
Drugmakers Ask To Appeal Overarching Conspiracy Claim
A group of pharmaceutical companies that failed to secure a pretrial win on an overarching conspiracy claim in a sprawling generic-drug antitrust enforcement action is asking a Connecticut federal judge to let them seek Second Circuit review, saying the ruling raises a novel legal issue.
-
January 30, 2026
Fanatics, Leagues Want Out Of Card Buyers' Antitrust Suit
Trading card customers accusing Fanatics of manipulating the market through its exclusive deals with the major sports leagues make premature and implausible conclusions, the collectibles giant told a New York federal judge in its bid to dismiss the suit.
-
January 30, 2026
US Rebukes WTO Siding With China On Energy Tax Credits
The U.S. Trade Representative condemned the World Trade Organization's decision to side with China in a dispute over energy tax credits passed during former President Joe Biden's term Friday, calling the global body's dispute resolution mechanism inadequate.
-
January 30, 2026
FTC Requires Facility Sales For $835M Healthcare Deal
The Federal Trade Commission reached an agreement Friday allowing Sevita Health to move ahead with an $835 million deal for BrightSpring Health Services Inc.'s community living business, conditioned on the sale of more than 100 facilities.
-
January 30, 2026
$2.7B Material Handling Tech Deal OK'd With DOJ Sales
Columbus McKinnon Corp. will have to sell its power chain hoist and chains businesses under a settlement with the U.S. Department of Justice permitting the company's $2.7 billion purchase of Kito Crosby Ltd. from KKR-managed funds.
-
January 30, 2026
FTC Warns 42 Law Firms Of DEI 'Anticompetitive Collusion'
The Federal Trade Commission announced Friday that it has sent warning letters to 42 major law firms for their purported participation in an outside diversity, equity and inclusion program, alleging their participation could constitute anticompetitive collusion.
-
January 30, 2026
DOJ Requires Divestitures For Reddy Ice-Arctic Glacier Tie-Up
The U.S. Department of Justice Antitrust Division is forcing Reddy Ice to divest assets in five geographic areas in order to win approval for a $126 million acquisition of competitor Arctic Glacier.
-
January 30, 2026
Snoop Dogg's Ice Cream Co. Wants To Mediate 'Swizzle' Claim
The rapper Snoop Dogg's ice cream company and multiple Edible Arrangements entities have asked a Connecticut federal court to send their trademark dispute over use of the word "Swizzle" to a magistrate judge for mediation and pause all deadlines in the case until that process is complete.
-
January 30, 2026
Drug Cos. Want Rethink Of DQ Bid Targeting Ex-Prosecutor
More than two dozen pharmaceutical companies accused of fixing generic-drug prices have again asked a Pennsylvania federal judge to disqualify a former Connecticut assistant attorney general now in private practice from representing insurers Humana Inc. and Molina Healthcare Inc. in a sprawling multidistrict litigation proceeding.
-
January 29, 2026
Apple Dodges Users' Deposition In Google Antitrust Case
A California federal judge has quashed a Christmas Eve deposition subpoena that sought information from Apple Inc. concerning dealings with Google LLC, saying users who accused Google of suppressing rival search engines through anticompetitive deals had no valid reason for the subpoena.
-
January 29, 2026
DOL Proposes Pharmacy Benefit Manager Fee Disclosure Rule
The U.S. Department of Labor's employee benefits subagency Thursday proposed a rule to require new fee disclosures from pharmacy benefit managers, which act as intermediaries between drugmakers, pharmacies and insurers, to help managers of employee health plans ensure PBM services are reasonably priced.
-
January 29, 2026
2 Foreign Cos. Escape Pa. Polyurethane Price-Fixing MDL
A Pennsylvania federal judge on Thursday unsealed his opinion from earlier this month dismissing two parent companies in Germany and China from multidistrict antitrust litigation that accuses several companies of conspiring to manipulate the prices of two chemicals used to make polyurethane, saying the court doesn't have jurisdiction.
Expert Analysis
-
Series
Law School's Missed Lessons: Skillful Persuasion
In many ways, law school teaches us how to argue, but when the ultimate goal is to get your client what they want, being persuasive through preparation and humility is the more likely key to success, says Michael Friedland at Friedland Cianfrani.
-
A Look At Trump 2.0 Antitrust Enforcement So Far
The first six months of President Donald Trump's second administration were marked by aggressive antitrust enforcement tempered by traditional structural remedies for mergers, but other unprecedented actions, like the firing of Federal Trade Commission Democrats, will likely stoke heated discussion ahead, says Richard Dagen at Axinn.
-
Litigation Inspiration: How To Respond After A Loss
Every litigator loses a case now and then, and the sting of that loss can become a medicine that strengthens or a poison that corrodes, depending on how the attorney responds, says Bennett Rawicki at Hilgers Graben.
-
The Metamorphosis Of The Major Questions Doctrine
The so-called major questions doctrine arose as a counterweight to Chevron deference over the past few decades, but invocations of the doctrine have persisted in the year since Chevron was overturned, suggesting it still has a role to play in reining in agency overreach, say attorneys at Crowell & Moring.
-
A Rapidly Evolving Landscape For Noncompetes In Healthcare
A wave of new state laws regulating noncompete agreements in the healthcare sector, varying in scope, approach and enforceability, are shaped by several factors unique to the industry and are likely to distort the market, say attorneys at Seyfarth.
-
Biotech Collaborations Can Ease Uncertainty Amid FDA Shift
As concerns persist that the U.S. Food and Drug Administration's reduced headcount will impede developments at already-strapped biotech companies, licensing and partnership transactions can provide the necessary funding and pathways to advance innovative products, say attorneys at Troutman.
-
Series
Playing Mah-Jongg Makes Me A Better Mediator
Mah-jongg rewards patience, pattern recognition, adaptability and keen observation, all skills that are invaluable to my role as a mediator, and to all mediating parties, says Marina Corodemus.
-
Tips For Business Users After 2 Key AI Copyright Decisions
Because two recent artificial intelligence copyright decisions from the Northern District of California — Bartz v. Anthropic and Kadrey v. Meta — came out mostly in favor of the developers using the plaintiffs' works to train large language models, business users should proceed with care, says Chris Wlach at Acxiom.
-
FTC Staff Cuts Unlikely To Curb Antitrust Enforcement Agenda
While Federal Trade Commission Chair Andrew Ferguson's recent commitment to reducing agency staff may seem at odds with the Trump administration's commitment to antitrust enforcement, a closer analysis shows that such reductions have little chance of derailing the president's efforts, say attorneys at Squire Patton.
-
Series
Law School's Missed Lessons: Navigating Client Trauma
Law schools don't train students to handle repeated exposure to clients' traumatic experiences, but for litigators practicing in areas like civil rights and personal injury, success depends on the ability to view cases clinically and to recognize when you may need to seek help, says Katie Bennett at Robins Kaplan.
-
Yacht Broker Case Highlights Industry Groups' Antitrust Risk
The Eleventh Circuit recently revived class claims against the International Yacht Brokers Association, signaling that commission-driven industries beyond real estate are vulnerable to antitrust challenges after the National Association of Realtors settled similar allegations last year, says Miles Santiago at the Southern University Law Center and Alex Hebert at Southern Compass.
-
Opinion
4 Former Justices Would Likely Frown On Litigation Funding
As courts increasingly confront cases involving hidden litigation finance contracts, the jurisprudence of four former U.S. Supreme Court justices establishes a constitutional framework that risks erosion by undisclosed financial interests, says Roland Eisenhuth at the American Property Casualty Insurance Association.
-
Takeaways From EU's Review Of Merger Control Guidelines
The European Commission’s newly launched consultation on the European Union’s merger guidelines will explore whether and how merger control should consider key policy objectives, such as innovation, investment incentives and security, say lawyers at Latham.
-
How Attys Can Use AI To Surface Narratives In E-Discovery
E-discovery has reached a turning point where document review is no longer just about procedural tasks like identifying relevance and redacting privilege — rather, generative artificial intelligence tools now allow attorneys to draw connections, extract meaning and tell a coherent story, says Rose Jones at Hilgers Graben.
-
Capital One Deal Approval Lights Up Path For Bank M&A
The federal banking regulators' recent approval of Capital One's acquisition of Discover signals the agencies' willingness to approve large transactions and a more favorable environment generally for bank mergers under the Trump administration, say attorneys at Arnold & Porter.